[Lyell syndrome following administration of erythromycin-sulfafurazole and morniflumate].
Raymond
F
F
Paillat
A
A
Gambert
C
C
Garnier
P
P
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002675:Child, Preschool; D004917:Erythromycin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009544:Niflumic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D013444:Sulfisoxazole / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009544:Niflumic Acid; D004917:Erythromycin; D013444:Sulfisoxazole; C027859:morniflumate
Syndrome de Lyell après administration d'érythromycine-sulfafurazole et de morniflumate.